<ul><li>Berlin-based AI company Aignostics has raised €31M ($34M) in Series B funding.</li><li>The funding round was led by ATHOS, with investments from Mayo Clinic and HTGF.</li><li>The funds will be used to improve target identification, translational research, and companion diagnostics.</li><li>Aignostics aims to launch new products, expand in the US, and collaborate with Mayo Clinic.</li></ul>

German startup Aignostics scores €31M to turn complex biomedical data into insights through AI: Know more

Discover more